Mental health and wellness; medical imaging and AI-based diagnostic software; and clinical trials technology proved most attractive to investors London, UK – 21 April 2022. Hampleton Partners’ latest Healthtech M&A Market Report highlights how the Covid-19 pandemic revealed the inadequacies and opportunities in the world’s healthcare systems and how venture and growth capital poured into digital health companies, raising a total of $57.2 billion in funding in 2021, an increase of 79 per cent from 2020. David Bell, director, Hampleton Partners, said: “Though the new investment has been significantly concentrated…
Read MoreMonday, April 29, 2024
